Marcelo Augusto Damasceno Góes

Mr. Marcelo Augusto Damasceno Góes


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MLMarco Luís
Marco Luís
MGMarcelo Augusto Damasceno Góes
Marcelo Augusto Damasceno Góes
Fátima Milhano SantosFátima Milhano Santos
Fátima Milhano Santos
JMJoana Mesquita
Joana Mesquita
PTPaulo Tavares-Ratado
Paulo Tavares-Ratado
Cândida Teixeira TomazCândida Teixeira Tomaz
Cândida Teixeira Tomaz
Monogenic disorders are a group of human diseases caused by mutations in single genes. While some disease-altering treatments offer relief and slow the progression of certain conditions, the majority of monogenic disorders still lack effective therapies. In recent years, gene therapy has appeared as a promising approach for addressing genetic disorders. However, despite advancements in gene manipulation tools and delivery systems, several challenges remain unresolved, including inefficient delivery, lack of sustained expression, immunogenicity, toxicity, capacity limitations, genomic integration risks, and limited tissue specificity. This review provides an overview of the plasmid-based gene therapy techniques and delivery methods currently employed for monogenic diseases, highlighting the challenges they face and exploring potential strategies to overcome these barriers.